You just read:

NIH Awards $7.5 Million Grant for AgeneBio HOPE4MCI Phase 3 Clinical Trial to Delay the Onset of Alzheimer's Dementia

News provided by

AgeneBio, Inc.

Sep 15, 2015, 07:00 ET